Ignite Creation Date:
2024-05-06 @ 6:57 PM
Last Modification Date:
2024-10-26 @ 2:58 PM
Study NCT ID:
NCT05847998
Status:
COMPLETED
Last Update Posted:
2024-03-15
First Post:
2023-02-16
Brief Title:
Second Generation DICART Prototype Validation
Sponsor:
Hospices Civils de Lyon
Organization:
Hospices Civils de Lyon
Study Overview
Official Title:
Second Generation DICART Prototype Validation for Patients With Acute Circulatory Failure
Status:
COMPLETED
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
DICART II
Brief Summary:
Capillary refill time CRT is a clinical sign for diagnosis of acute circulatory failure and response to treatment but is also associated with prognosis in patient with shock
CRT is clinically evaluated by physician with a high risk of inter and intra evaluator variations depending for example on measurement site pressure applicated or visual evaluation
The investigator hypothesizes that CRT measurement with second generation DICART prototype will be well correlated with clinical measurement
CRT is clinically evaluated by physician with a high risk of inter and intra evaluator variations depending for example on measurement site pressure applicated or visual evaluation
The investigator hypothesizes that CRT measurement with second generation DICART prototype will be well correlated with clinical measurement
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2021-A02595-36 | OTHER | IDRCB | None |